Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Serafima Scherbina"'
Autor:
Aleria Aitova, Serafima Scherbina, Andrey Berezhnoy, Mikhail Slotvitsky, Valeriya Tsvelaya, Tatyana Sergeeva, Elena Turchaninova, Elizaveta Rybkina, Sergey Bakumenko, Ilya Sidorov, Mikhail A. Popov, Vladislav Dontsov, Evgeniy G. Agafonov, Anton E. Efimov, Igor Agapov, Dmitriy Zybin, Dmitriy Shumakov, Konstantin Agladze
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 12, p 10406 (2023)
Myocardial remodeling is an inevitable risk factor for cardiac arrhythmias and can potentially be corrected with cell therapy. Although the generation of cardiac cells ex vivo is possible, specific approaches to cell replacement therapy remain unclea
Externí odkaz:
https://doaj.org/article/96e289df9f5f45e6bf8bd428df7566ca
Autor:
Mikhail Slotvitsky, Andrey Berezhnoy, Serafima Scherbina, Beatrisa Rimskaya, Valerya Tsvelaya, Victor Balashov, Anton E. Efimov, Igor Agapov, Konstantin Agladze
Publikováno v:
Micromachines, Vol 14, Iss 1, p 51 (2022)
Induced pluripotent stem cells (iPSCs) constitute a potential source of patient-specific human cardiomyocytes for a cardiac cell replacement therapy via intramyocardial injections, providing a major benefit over other cell sources in terms of immune
Externí odkaz:
https://doaj.org/article/2afb793f6ca641a4abaab595d36adc74
Autor:
Aitova Aleria, Serafima Scherbina, Andrey Berezhnoy, Mikhail Slotvitsky, Valeriya Tsvelaya, Tatyana Sergeeva, Elena Turchaninova, Elizaveta Rybkina, Sergey Bakumenko, Ilya Sidorov, Mikhail Popov, Vladislav Dontsov, Evgeniy Agafonov, Anton E. Efimov, Igor Agapov, Dmitriy Zybin, Dmitriy Shumakov, Konstantin Agladze
Myocardial remodeling is an inevitable risk factor for cardiac arrhythmias and can potentially be corrected with cell therapy. Although the generation of cardiac cells ex vivo is possible, specific approaches to cell replacement therapy remain unclea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::894091a33b683f4c32ea0ccb7fe12823
